Mantle cell lymphoma (MCL) relapsed or refractory in patients who have previously received at least two lines of systemic therapy including a Bruton tyrosine kinase (BTK) inhibitor; or Chronic ...
TORONTO, Jan. 27, 2026 /CNW/ - Eli Lilly Canada, Inc announced today that Jaypirca ® (pirtobrutinib, 100 mg & 50 mg tablets) is now approved and available for use as monotherapy for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results